Anti-spasmodic Drugs Market Insights, Global Outlook and Forecast 2022-2028
Anti-spasmodic Drugs Market Insights, Global Outlook and Forecast 2022-2028
Discover the latest insights into the booming Anti spasmodic Drugs Market. This report analyzes market size, growth trends (CAGR ), key players, and regional performance, offering valuable data for investors and industry professionals. Explore market drivers, restraints, and future projections for -.
Exclusive deal : 20% Instant discount on Direct purchases! Don't wait—claim your discount today!
Antispasmodic drugs such as dicyclomine (Bentyl) and hyoscyamine (Levsin) relieve the stomach cramps brought on by IBS by relaxing the smooth muscle of the gut. They also may cause constipation, so they aren't usually prescribed for people who suffer from IBS-C. Other side effects are dry mouth, drowsiness, and blurred vision.
The latest research study released by Market IntelliX evaluates market size and forecasts of Anti-spasmodic Drugs in Global, including the following market information:
Global Anti-spasmodic Drugs Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Anti-spasmodic Drugs market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Antimuscarinics Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Anti-spasmodic Drugs include Pfizer, Allergan, Ipsen, Teva Pharmaceuticals, Novartis, Johnson & Johnson, Takeda Pharmaceutical, Sun Pharmaceutical Industries and Merz Pharma, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MI has surveyed the Anti-spasmodic Drugs companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Market Segmentations:
Global Anti-spasmodic Drugs Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Anti-spasmodic Drugs Market Segment Percentages, by Type, 2021 (%)
Antimuscarinics
Smooth Muscle Relaxants
Global Anti-spasmodic Drugs Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Anti-spasmodic Drugs Market Segment Percentages, by Application, 2021 (%)
Offline Channel
Online Channel
Global Anti-spasmodic Drugs Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Anti-spasmodic Drugs Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Anti-spasmodic Drugs revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Anti-spasmodic Drugs revenues share in global market, 2021 (%)
The report presents profiles of competitors in the market, Some of the prominent key players covered:
Pfizer
Allergan
Ipsen
Teva Pharmaceuticals
Novartis
Johnson & Johnson
Takeda Pharmaceutical
Sun Pharmaceutical Industries
Merz Pharma
Mylan
Fresenius Kabi
Endo International
Daewoong Pharmaceutical
Acorda Therapeutics
SteriMax
Emcure Pharmaceuticals
Sawai Pharmaceutical
Orient Pharma
Key Takeaways from this Report
Evaluate market potential through analyzing growth rates (CAGR %), Volume (Units) and Value ($M) data given at country level – for product types, end use applications and by different industry verticals.
Understand the different dynamics influencing the market – key driving factors, challenges and hidden opportunities.
Get in-depth insights on your competitor performance – market shares, strategies, financial benchmarking, product benchmarking, SWOT and more.
Analyze the sales and distribution channels across key geographies to improve top-line revenues.
Understand the industry supply chain with a deep-dive on the value augmentation at each step, in order to optimize value and bring efficiencies in your processes.
Get a quick outlook on the market entropy – M&A’s, deals, partnerships, product launches of all key players for the past 4 years.
Evaluate the supply-demand gaps, import-export statistics and regulatory landscape for more than top 20 countries globally for the market.
1 Introduction to Research & Analysis Reports
1.1 Anti-spasmodic Drugs Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Anti-spasmodic Drugs Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Anti-spasmodic Drugs Overall Market Size
2.1 Global Anti-spasmodic Drugs Market Size: 2021 VS 2028
2.2 Global Anti-spasmodic Drugs Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Anti-spasmodic Drugs Players in Global Market
3.2 Top Global Anti-spasmodic Drugs Companies Ranked by Revenue
3.3 Global Anti-spasmodic Drugs Revenue by Companies
3.4 Top 3 and Top 5 Anti-spasmodic Drugs Companies in Global Market, by Revenue in 2021
3.5 Global Companies Anti-spasmodic Drugs Product Type
3.6 Tier 1, Tier 2 and Tier 3 Anti-spasmodic Drugs Players in Global Market
3.6.1 List of Global Tier 1 Anti-spasmodic Drugs Companies
3.6.2 List of Global Tier 2 and Tier 3 Anti-spasmodic Drugs Companies
4 Market Sights by Product
4.1 Overview
4.1.1 by Type - Global Anti-spasmodic Drugs Market Size Markets, 2021 & 2028
4.1.2 Antimuscarinics
4.1.3 Smooth Muscle Relaxants
4.2 By Type - Global Anti-spasmodic Drugs Revenue & Forecasts
4.2.1 By Type - Global Anti-spasmodic Drugs Revenue, 2017-2022
4.2.2 By Type - Global Anti-spasmodic Drugs Revenue, 2023-2028
4.2.3 By Type - Global Anti-spasmodic Drugs Revenue Market Share, 2017-2028
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Anti-spasmodic Drugs Market Size, 2021 & 2028
5.1.2 Offline Channel
5.1.3 Online Channel
5.2 By Application - Global Anti-spasmodic Drugs Revenue & Forecasts
5.2.1 By Application - Global Anti-spasmodic Drugs Revenue, 2017-2022
5.2.2 By Application - Global Anti-spasmodic Drugs Revenue, 2023-2028
5.2.3 By Application - Global Anti-spasmodic Drugs Revenue Market Share, 2017-2028
6 Sights by Region
6.1 By Region - Global Anti-spasmodic Drugs Market Size, 2021 & 2028
6.2 By Region - Global Anti-spasmodic Drugs Revenue & Forecasts
6.2.1 By Region - Global Anti-spasmodic Drugs Revenue, 2017-2022
6.2.2 By Region - Global Anti-spasmodic Drugs Revenue, 2023-2028
6.2.3 By Region - Global Anti-spasmodic Drugs Revenue Market Share, 2017-2028
6.3 North America
6.3.1 By Country - North America Anti-spasmodic Drugs Revenue, 2017-2028
6.3.2 US Anti-spasmodic Drugs Market Size, 2017-2028
6.3.3 Canada Anti-spasmodic Drugs Market Size, 2017-2028
6.3.4 Mexico Anti-spasmodic Drugs Market Size, 2017-2028
6.4 Europe
6.4.1 By Country - Europe Anti-spasmodic Drugs Revenue, 2017-2028
6.4.2 Germany Anti-spasmodic Drugs Market Size, 2017-2028
6.4.3 France Anti-spasmodic Drugs Market Size, 2017-2028
6.4.4 U.K. Anti-spasmodic Drugs Market Size, 2017-2028
6.4.5 Italy Anti-spasmodic Drugs Market Size, 2017-2028
6.4.6 Russia Anti-spasmodic Drugs Market Size, 2017-2028
6.4.7 Nordic Countries Anti-spasmodic Drugs Market Size, 2017-2028
6.4.8 Benelux Anti-spasmodic Drugs Market Size, 2017-2028
6.5 Asia
6.5.1 By Region - Asia Anti-spasmodic Drugs Revenue, 2017-2028
6.5.2 China Anti-spasmodic Drugs Market Size, 2017-2028
6.5.3 Japan Anti-spasmodic Drugs Market Size, 2017-2028
6.5.4 South Korea Anti-spasmodic Drugs Market Size, 2017-2028
6.5.5 Southeast Asia Anti-spasmodic Drugs Market Size, 2017-2028
6.5.6 India Anti-spasmodic Drugs Market Size, 2017-2028
6.6 South America
6.6.1 By Country - South America Anti-spasmodic Drugs Revenue, 2017-2028
6.6.2 Brazil Anti-spasmodic Drugs Market Size, 2017-2028
6.6.3 Argentina Anti-spasmodic Drugs Market Size, 2017-2028
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Anti-spasmodic Drugs Revenue, 2017-2028
6.7.2 Turkey Anti-spasmodic Drugs Market Size, 2017-2028
6.7.3 Israel Anti-spasmodic Drugs Market Size, 2017-2028
6.7.4 Saudi Arabia Anti-spasmodic Drugs Market Size, 2017-2028
6.7.5 UAE Anti-spasmodic Drugs Market Size, 2017-2028
7 Players Profiles
7.1 Pfizer
7.1.1 Pfizer Corporate Summary
7.1.2 Pfizer Business Overview
7.1.3 Pfizer Anti-spasmodic Drugs Major Product Offerings
7.1.4 Pfizer Anti-spasmodic Drugs Revenue in Global Market (2017-2022)
7.1.5 Pfizer Key News
7.2 Allergan
7.2.1 Allergan Corporate Summary
7.2.2 Allergan Business Overview
7.2.3 Allergan Anti-spasmodic Drugs Major Product Offerings
7.2.4 Allergan Anti-spasmodic Drugs Revenue in Global Market (2017-2022)
7.2.5 Allergan Key News
7.3 Ipsen
7.3.1 Ipsen Corporate Summary
7.3.2 Ipsen Business Overview
7.3.3 Ipsen Anti-spasmodic Drugs Major Product Offerings
7.3.4 Ipsen Anti-spasmodic Drugs Revenue in Global Market (2017-2022)
7.3.5 Ipsen Key News
7.4 Teva Pharmaceuticals
7.4.1 Teva Pharmaceuticals Corporate Summary
7.4.2 Teva Pharmaceuticals Business Overview
7.4.3 Teva Pharmaceuticals Anti-spasmodic Drugs Major Product Offerings
7.4.4 Teva Pharmaceuticals Anti-spasmodic Drugs Revenue in Global Market (2017-2022)
7.4.5 Teva Pharmaceuticals Key News
7.5 Novartis
7.5.1 Novartis Corporate Summary
7.5.2 Novartis Business Overview
7.5.3 Novartis Anti-spasmodic Drugs Major Product Offerings
7.5.4 Novartis Anti-spasmodic Drugs Revenue in Global Market (2017-2022)
7.5.5 Novartis Key News
7.6 Johnson & Johnson
7.6.1 Johnson & Johnson Corporate Summary
7.6.2 Johnson & Johnson Business Overview
7.6.3 Johnson & Johnson Anti-spasmodic Drugs Major Product Offerings
7.6.4 Johnson & Johnson Anti-spasmodic Drugs Revenue in Global Market (2017-2022)
7.6.5 Johnson & Johnson Key News
7.7 Takeda Pharmaceutical
7.7.1 Takeda Pharmaceutical Corporate Summary
7.7.2 Takeda Pharmaceutical Business Overview
7.7.3 Takeda Pharmaceutical Anti-spasmodic Drugs Major Product Offerings
7.7.4 Takeda Pharmaceutical Anti-spasmodic Drugs Revenue in Global Market (2017-2022)
7.7.5 Takeda Pharmaceutical Key News
7.8 Sun Pharmaceutical Industries
7.8.1 Sun Pharmaceutical Industries Corporate Summary
7.8.2 Sun Pharmaceutical Industries Business Overview
7.8.3 Sun Pharmaceutical Industries Anti-spasmodic Drugs Major Product Offerings
7.8.4 Sun Pharmaceutical Industries Anti-spasmodic Drugs Revenue in Global Market (2017-2022)
7.8.5 Sun Pharmaceutical Industries Key News
7.9 Merz Pharma
7.9.1 Merz Pharma Corporate Summary
7.9.2 Merz Pharma Business Overview
7.9.3 Merz Pharma Anti-spasmodic Drugs Major Product Offerings
7.9.4 Merz Pharma Anti-spasmodic Drugs Revenue in Global Market (2017-2022)
7.9.5 Merz Pharma Key News
7.10 Mylan
7.10.1 Mylan Corporate Summary
7.10.2 Mylan Business Overview
7.10.3 Mylan Anti-spasmodic Drugs Major Product Offerings
7.10.4 Mylan Anti-spasmodic Drugs Revenue in Global Market (2017-2022)
7.10.5 Mylan Key News
7.11 Fresenius Kabi
7.11.1 Fresenius Kabi Corporate Summary
7.11.2 Fresenius Kabi Business Overview
7.11.3 Fresenius Kabi Anti-spasmodic Drugs Major Product Offerings
7.11.4 Fresenius Kabi Anti-spasmodic Drugs Revenue in Global Market (2017-2022)
7.11.5 Fresenius Kabi Key News
7.12 Endo International
7.12.1 Endo International Corporate Summary
7.12.2 Endo International Business Overview
7.12.3 Endo International Anti-spasmodic Drugs Major Product Offerings
7.12.4 Endo International Anti-spasmodic Drugs Revenue in Global Market (2017-2022)
7.12.5 Endo International Key News
7.13 Daewoong Pharmaceutical
7.13.1 Daewoong Pharmaceutical Corporate Summary
7.13.2 Daewoong Pharmaceutical Business Overview
7.13.3 Daewoong Pharmaceutical Anti-spasmodic Drugs Major Product Offerings
7.13.4 Daewoong Pharmaceutical Anti-spasmodic Drugs Revenue in Global Market (2017-2022)
7.13.5 Daewoong Pharmaceutical Key News
7.14 Acorda Therapeutics
7.14.1 Acorda Therapeutics Corporate Summary
7.14.2 Acorda Therapeutics Business Overview
7.14.3 Acorda Therapeutics Anti-spasmodic Drugs Major Product Offerings
7.14.4 Acorda Therapeutics Anti-spasmodic Drugs Revenue in Global Market (2017-2022)
7.14.5 Acorda Therapeutics Key News
7.15 SteriMax
7.15.1 SteriMax Corporate Summary
7.15.2 SteriMax Business Overview
7.15.3 SteriMax Anti-spasmodic Drugs Major Product Offerings
7.15.4 SteriMax Anti-spasmodic Drugs Revenue in Global Market (2017-2022)
7.15.5 SteriMax Key News
7.16 Emcure Pharmaceuticals
7.16.1 Emcure Pharmaceuticals Corporate Summary
7.16.2 Emcure Pharmaceuticals Business Overview
7.16.3 Emcure Pharmaceuticals Anti-spasmodic Drugs Major Product Offerings
7.16.4 Emcure Pharmaceuticals Anti-spasmodic Drugs Revenue in Global Market (2017-2022)
7.16.5 Emcure Pharmaceuticals Key News
7.17 Sawai Pharmaceutical
7.17.1 Sawai Pharmaceutical Corporate Summary
7.17.2 Sawai Pharmaceutical Business Overview
7.17.3 Sawai Pharmaceutical Anti-spasmodic Drugs Major Product Offerings
7.17.4 Sawai Pharmaceutical Anti-spasmodic Drugs Revenue in Global Market (2017-2022)
7.17.5 Sawai Pharmaceutical Key News
7.18 Orient Pharma
7.18.1 Orient Pharma Corporate Summary
7.18.2 Orient Pharma Business Overview
7.18.3 Orient Pharma Anti-spasmodic Drugs Major Product Offerings
7.18.4 Orient Pharma Anti-spasmodic Drugs Revenue in Global Market (2017-2022)
7.18.5 Orient Pharma Key News
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
Research Methodology:
Anti spasmodic Drugs Market Size Estimation
To estimate market size and trends, we use a combination of top-down and bottom-up methods. This allows us to evaluate the market from various perspectives—by company, region, product type, and end users.
Our estimates are based on actual sales data, excluding any discounts. Segment breakdowns and market shares are calculated using weighted averages based on usage rates and average prices. Regional insights are determined by how widely a product or service is adopted in each area.
Key companies are identified through secondary sources like industry reports and company filings. We then verify revenue estimates and other key data points through primary research, including interviews with industry experts, company executives, and decision-makers.
We take into account all relevant factors that could influence the market and validate our findings with real-world input. Our final insights combine both qualitative and quantitative data to provide a well-rounded view. Please note, these estimates do not account for unexpected changes such as inflation, economic downturns, or policy shifts.
Data Source
Secondary Sources
This study draws on a wide range of secondary sources, including press releases, annual reports, non-profit organizations, industry associations, government agencies, and customs data. We also referred to reputable databases and directories such as Bloomberg, Wind Info, Hoovers, Factiva, Trading Economics, Statista, and others. Additional references include investor presentations, company filings (e.g., SEC), economic data, and documents from regulatory and industry bodies.
These sources were used to gather technical and market-focused insights, identify key players, analyze market segmentation and classification, and track major trends and developments across industries.
| Market Size |
|
|
| Market Position of Top Company |
|
|
| Qualitative Analysis |
|
|
Primary Sources
As part of our primary research, we interviewed a variety of stakeholders from both the supply and demand sides to gather valuable qualitative and quantitative insights.
On the supply side, we spoke with product manufacturers, competitors, industry experts, research institutions, distributors, traders, and raw material suppliers. On the demand side, we engaged with business leaders, marketing and sales heads, technology and innovation directors, supply chain executives, and end users across key organizations.
These conversations helped us better understand market segmentation, pricing, applications, leading players, supply chains, demand trends, industry outlook, and key market dynamics—including risks, opportunities, barriers, and strategic developments.
Key Data Information from Primary Sources
| Primary Sources | Parameters | Key Data |
| Market Segments(by Application, by Type) |
|
|
| Total Market |
|
|